"Vitamin B12 status and rate of brain volume loss in community-dwelling elderly"
It contains a bacteriostatic preservative that helps inhibit the growth of bacteria after the vial has been opened, making it suitable for repeated laboratory use under controlled research conditions
Here are two of the most notable experiments to date: In an 11-day study, obese mice treated with 20mg/kg of 5-amino-1MQ trice daily experienced a 5.1% weight reduction from baseline, while control mice gained 1.4% in body weight
ive used it for 4 weeks now and the difference is major
According to the NICE Clinical Knowledge Summary (CKS) and the British National Formulary (BNF) , the standard treatment for B12 deficiency without neurological symptoms involves: Hydroxocobalamin 1 mg intramuscularly three times weekly for two weeks Followed by maintenance doses of 1 mg every three months For patients with neurological symptoms (such as paraesthesia, numbness, cognitive changes, or gait disturbances), more intensive treatment is required: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs Followed by 1 mg every two months for maintenance Pernicious anaemia , an autoimmune condition where the body cannot produce intrinsic factor, requires lifelong treatment
doi: 10.1016/j.clnu.2011.01.003 [DOI] [PubMed] [Google Scholar] 31.Sung SH, Kim NH, Hong SP, Lee JK, Choi SJ